Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

J Clin Invest. 1998 Mar 1;101(5):1133-41. doi: 10.1172/JCI1472.

Abstract

CD40-CD40-ligand (CD154) interactions play a critical role in immune activation. Using replication defective adenovirus encoding mouse CD154 (Ad-CD154), we modified human chronic lymphocytic leukemia B cells to express a functional ligand for CD40. This not only induces expression of immune accessory molecules on the infected cell, but also allows it to trans-activate noninfected bystander leukemia B cells. Also, factors that impair the antigen-presenting capacity of leukemia B cells are downmodulated. Ad-CD154- infected leukemia cells are highly effective stimulators in mixed lymphocyte reactions and can induce generation of cytotoxic T lymphocytes specific for autologous nonmodified leukemia cells. As such, Ad-CD154 can induce a host antileukemia response that may have therapeutic potential.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Antigen Presentation / genetics
  • Antigens, CD / immunology
  • B-Lymphocytes / immunology*
  • CD40 Ligand
  • Cytotoxicity Tests, Immunologic
  • DNA, Complementary / genetics
  • Flow Cytometry
  • Gene Expression
  • Gene Transfer Techniques
  • Genetic Therapy / methods
  • Genetic Vectors
  • HeLa Cells
  • Humans
  • Immunity, Active / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Lymphocyte Culture Test, Mixed
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / immunology*
  • Polymerase Chain Reaction
  • Recombination, Genetic
  • T-Lymphocytes, Cytotoxic / immunology
  • Transcriptional Activation
  • Tumor Cells, Cultured

Substances

  • Antigens, CD
  • DNA, Complementary
  • Membrane Glycoproteins
  • CD40 Ligand